AngioDynamics ANGO Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.
The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about AngioDynamics's additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AngioDynamics's additional paid-in capital?
- AngioDynamics (ANGO) reported additional paid-in capital of $632.18M in Q4 2025.
- How has AngioDynamics's additional paid-in capital changed year-over-year?
- AngioDynamics's additional paid-in capital increased by 2.0% year-over-year, from $619.55M to $632.18M.
- What is the long-term trend for AngioDynamics's additional paid-in capital?
- Over 4 years (2021 to 2025), AngioDynamics's additional paid-in capital has grown at a 2.0% compound annual growth rate (CAGR), from $573.51M to $621.19M.
- What does additional paid-in capital mean?
- Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.